The Yorl business said it is now signing multiple new contracts with global market-leading pharmaceutical companies ...

Schematic representation of the assay. (Photo credit: Justo et al., 2024) Using the knowledge gained in the sandwich ELAA ...

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” in its ...

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” ...

Aptamer Group, a developer of novel Optimer ® binders to enable innovation in the life sciences sector, says it is gaining ...

So far, one aptamer drug that binds to vascular endothelial growth factor has been approved for age-related macular degeneration. However, aptamers are also being developed as anticoagulants and ...

(Image: Wikimedia Commons, CC BY 4.0) Aptamers can be used as therapeutic agents, targeting specific disease-related molecules or pathways. For example, the FDA-approved aptamer drug Pegaptanib ...

Biologists at the University of the Philippines (UP) College of Science have developed an alternative and more cost-effective ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

Researchers at the University of the Philippines-Diliman (UPD) and international collaborators have developed a new detection ...

When metabolite binds (+M), the switching sequence is incorporated into the aptamer domain, and the expression platform folds into a terminator stem-loop (T), causing transcription to abort.